These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2523936)

  • 1. IL-1 and tumor necrosis factor. Similarities and differences in stimulation of expression of alternative pathway of complement and IFN-beta 2/IL-6 genes in human fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Jun; 142(11):3862-7. PubMed ID: 2523936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced synthesis of factor B induced by tumor necrosis factor in human skin fibroblasts is decreased by IL-4.
    Katz Y; Strunk RC
    J Immunol; 1990 Jun; 144(12):4675-80. PubMed ID: 2141041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-13 results in differential regulation of the complement proteins C3 and factor B in tumour necrosis factor (TNF)-stimulated fibroblasts.
    Katz Y; Stav D; Barr J; Passwell JH
    Clin Exp Immunol; 1995 Jul; 101(1):150-6. PubMed ID: 7621584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of complement components of the alternative pathway (C3 and factor B) by the human alveolar type II epithelial cell line A549.
    Zhao YX; Andoh A; Shimada M; Takaya H; Hata K; Fujiyama Y; Bamda T
    Int J Mol Med; 2000 Apr; 5(4):415-9. PubMed ID: 10719060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts.
    Katz Y; Nadiv O; Rapoport MJ; Loos M
    Clin Exp Immunol; 2000 Apr; 120(1):22-9. PubMed ID: 10759759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interferon-gamma on complement gene expression in different cell types.
    Lappin DF; Guc D; Hill A; McShane T; Whaley K
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):437-42. PubMed ID: 1531292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of complement alternative pathway proteins by endothelial cells. Differential regulation by interleukin 1 and glucocorticoids.
    Dauchel H; Julen N; Lemercier C; Daveau M; Ozanne D; Fontaine M; Ripoche J
    Eur J Immunol; 1990 Aug; 20(8):1669-75. PubMed ID: 2145163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiinflammatory effects of polypeptide growth factors. Platelet-derived growth factor, epidermal growth factor, and fibroblast growth factor inhibit the cytokine-induced expression of the alternative complement pathway activator factor B in human fibroblasts.
    Circolo A; Pierce GF; Katz Y; Strunk RC
    J Biol Chem; 1990 Mar; 265(9):5066-71. PubMed ID: 1690734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 6 stimulates synthesis of complement proteins factor B and C3 in human skin fibroblasts.
    Katz Y; Revel M; Strunk RC
    Eur J Immunol; 1989 Jun; 19(6):983-8. PubMed ID: 2473911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of keratinocyte growth factor gene expression in human skin fibroblasts.
    Tang A; Gilchrest BA
    J Dermatol Sci; 1996 Jan; 11(1):41-50. PubMed ID: 8867766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 alpha, interleukin 6 and tumor necrosis factor alpha increase the synthesis and expression of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro.
    Berge V; Johnson E; Berge KE
    APMIS; 1996 Mar; 104(3):213-9. PubMed ID: 8611196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-gamma and IL-1.
    Brooimans RA; van der Ark AA; Buurman WA; van Es LA; Daha MR
    J Immunol; 1990 May; 144(10):3835-40. PubMed ID: 2139673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of the interferon-beta 2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines.
    Walther Z; May LT; Sehgal PB
    J Immunol; 1988 Feb; 140(3):974-7. PubMed ID: 3276786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 and tumor necrosis factor-mediated regulation of C3 gene expression in human astroglioma cells.
    Barnum SR; Jones JL; Benveniste EN
    Glia; 1993 Mar; 7(3):225-36. PubMed ID: 8454308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human keratinocytes produce the complement inhibitor factor H: synthesis is regulated by interferon-gamma.
    Timár KK; Pasch MC; van den Bosch NH; Jarva H; Junnikkala S; Meri S; Bos JD; Asghar SS
    Mol Immunol; 2006 Feb; 43(4):317-25. PubMed ID: 16310045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of C2 and C3 gene expression of human peripheral blood monocytes by interleukin 1 beta, interferon gamma, tumor necrosis factor alpha and lipopolysaccharide.
    Shimizu H; Sakano T; Fujie A; Nishimura S; Ueda K
    Experientia; 1992 Dec; 48(11-12):1148-50. PubMed ID: 1473581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation of complement factor H and C3 expression by TNF-alpha in the rat. In vitro and in vivo studies.
    Julen N; Davrinche C; Ozanne D; Lebreton JP; Fontaine M; Ripoche J; Daveau M
    Mol Immunol; 1992; 29(7-8):983-8. PubMed ID: 1386144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon.
    Oliveira IC; Sciavolino PJ; Lee TH; Vilcek J
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9049-53. PubMed ID: 1409601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-alpha stimulates the biosynthesis of complement C3 and factor B by human umbilical cord vein endothelial cells.
    Kawakami Y; Watanabe Y; Yamaguchi M; Sakaguchi H; Kono I; Ueki A
    Cancer Lett; 1997 Jun; 116(1):21-6. PubMed ID: 9177453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor.
    Beresini MH; Lempert MJ; Epstein LB
    J Immunol; 1988 Jan; 140(2):485-93. PubMed ID: 3121746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.